SEC Form 4 · accession 0001041889-16-000060
PSYCHEMEDICS CORP · PMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Raymond C Kubacki Jr.
Officer — Chairman, CEO & President · Director
Period of report
May 12, 2016
Accepted (ET)
May 16, 2016 · 5:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000806517
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $13.82 | May 12, 2016 | A | 42,000 | A | — | May 12, 2026 | Common Stock, $.005 Par Value | 42,000 | 42,000 | D |
Explanation of responses
- F1The option becomes exercisable with respect to 25% of the shares on the first anniversary date of grant, and with respect to an additional 25% on each of the three anniversary dates thereafter, so long as the recipient is in the continuous employ of the Issuer through each such respective vesting date.